SKI Market

A+| A| A-|

Indian Indices

Sensex

75,183.36 -135.03
( -0.18%)

Global Indices

Nasdaq

50,030.26 645.37
(1.31%)

Dow Jones

7,453.29 78.68
(1.07%)

Hang Seng

61,747.25 1,942.84
(3.25%)

Nikkei 225

10,425.97 95.42
(0.92%)

Forex

USD-INR

96.52 0.30
(0.32%)

EUR-INR

112.16 0.19
(0.17%)

GBP-INR

129.37 0.68
(0.52%)

JPY-INR

0.61 0.00
(0.22%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

BSE Focused IT

Industry : Stock Exchanges

BSE Code

ISIN Demat

Book Value()

1196

N.A

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

22.03

EPS(TTM)

Face Value()

Div & Yield %

100

2.97

Back

Bliss GVS Pharma consolidated net profit rises 12.32% in the September 2025 quarter

Nov 07,2025

Net profit of Bliss GVS Pharma rose 12.32% to Rs 27.25 crore in the quarter ended September 2025 as against Rs 24.26 crore during the previous quarter ended September 2024. Sales rose 12.27% to Rs 244.40 crore in the quarter ended September 2025 as against Rs 217.68 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	244.40	217.68	12
OPM %	13.00	19.05	-
PBDT	48.89	42.69	15
PBT	40.63	35.71	14
NP	27.25	24.26	12

75,183.36 -135.03 ( -0.18%)

50,030.26 645.37 (1.31%)

7,453.29 78.68 (1.07%)

61,747.25 1,942.84 (3.25%)

10,425.97 95.42 (0.92%)

96.52 0.30 (0.32%)

112.16 0.19 (0.17%)

129.37 0.68 (0.52%)

0.61 0.00 (0.22%)